Thursday, 10 April 2025 04:21 PM EDT ET
The Food and Drug Administration said Thursday it plans to replace animal testing in the development of monoclonal antibody therapies and other drugs with "human-relevant methods," including the use of artificial intelligence-based models.
© 2025 Thomson/Reuters. All rights reserved.
View on Newsmax